SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

SR One Closes Second Venture Fund at $600M

Frances Benson 3/27/23 Frances Benson 3/27/23

SR One Closes Second Venture Fund at $600M

Read More

Mineralys Therapeutics prices $221M IPO

Frances Benson 2/14/23 Frances Benson 2/14/23

Mineralys Therapeutics prices $221M IPO

Read More

Nimbus Therapeutics TYK2 program to be acquired by Takeda for $4B in upfront cash and up to $2B in potential commercial milestone payments

Frances Benson 12/13/22 Frances Benson 12/13/22

Nimbus Therapeutics TYK2 program to be acquired by Takeda for $4B in upfront cash and up to $2B in potential commercial milestone payments

Read More

Arcellx announces strategic collaboration with Kite, a Gilead Company, to co-develop and co- commercialize late- stage clinical CART-ddBCMA in multiple myeloma

Frances Benson 12/9/22 Frances Benson 12/9/22

Arcellx announces strategic collaboration with Kite, a Gilead Company, to co-develop and co- commercialize late- stage clinical CART-ddBCMA in multiple myeloma

Read More

MiroBio to be acquired by Gilead Sciences for $405M

Frances Benson 8/4/22 Frances Benson 8/4/22

MiroBio to be acquired by Gilead Sciences for $405M

Read More

Ancora Biotech lead clinical asset, TeneoTwo, to be acquired by AstraZeneca for up to $1.27B

Frances Benson 7/5/22 Frances Benson 7/5/22

Ancora Biotech lead clinical asset, TeneoTwo, to be acquired by AstraZeneca for up to $1.27B

Read More

Turning Point Therapeutics to be acquired by Bristol Myers Squibb for $4.1B

Frances Benson 6/3/22 Frances Benson 6/3/22

Turning Point Therapeutics to be acquired by Bristol Myers Squibb for $4.1B

Read More

Arcellx prices $142.3M IPO

Frances Benson 2/8/22 Frances Benson 2/8/22

Arcellx prices $142.3M IPO

Read More

Pandion Therapeutics acquired by Merck for $1.85BN

Frances Benson 4/1/21 Frances Benson 4/1/21

Pandion Therapeutics acquired by Merck for $1.85BN

Read More

Design Therapeutics prices $276M IPO

Frances Benson 3/30/21 Frances Benson 3/30/21

Design Therapeutics prices $276M IPO

Read More

SR One adds Venture Partners to deepen operational expertise

Frances Benson 2/11/21 Frances Benson 2/11/21

SR One adds Venture Partners to deepen operational expertise

Read More

SR One Raises $500M; Completes Spinout from GSK

Frances Benson 11/19/20 Frances Benson 11/19/20

SR One Raises $500M; Completes Spinout from GSK

Read More

Nobel Prize in chemistry awarded to CRISPR Therapeutics founder Emmanuelle Charpentier

Frances Benson 10/20/20 Frances Benson 10/20/20

Nobel Prize in chemistry awarded to CRISPR Therapeutics founder Emmanuelle Charpentier

Read More

Principia Biopharma acquired by Sanofi for $3.7BN

Frances Benson 8/17/20 Frances Benson 8/17/20

Principia Biopharma acquired by Sanofi for $3.7BN

Read More